LiveRamp Holdings, Inc. Chief Executive Officer Scott E. Howe filed a Form 4 on August 24, 2026, disclosing the withholding of shares by the issuer to cover taxes arising from the vesting of restricted stock units on August 22, 2026.
Vihan Sharma, Chief Revenue Officer of LiveRamp Holdings, Inc., filed a Form 4 on August 24, 2026, disclosing the withholding of shares by the issuer to cover tax obligations arising from the vesting of restricted stock units on August 22, 2026.
Jerry C. Jones, Chief Ethics & Legal Officer of LiveRamp Holdings, Inc., filed a Form 4 on August 24, 2026, disclosing two share-withholding transactions on August 22, 2026, tied to the vesting of restricted stock units.
Julie Marie O'Daniel, Chief Legal Officer of Valvoline Inc., filed a statement of changes in beneficial ownership on August 24, 2026, reporting a sale of common stock that took place on August 21, 2026.
Sarah Elizabeth Schubach, Chief Accounting Officer of Dropbox, Inc. (NASDAQ:DBX), filed a Form 4 on August 24, 2026, reporting the sale of 1,631 shares of Class A Common Stock on August 20, 2026.
A Form 4 filed with the SEC on August 24, 2026, discloses that Aldo J. Polak, a director of EVERTEC, Inc. (NYSE:EVTC), sold 1,000 shares of common stock on August 21, 2026.
Garrett L. Chase, Senior Vice President and Chief Financial Officer of Viasat Inc, filed a statement of changes in beneficial ownership on August 24, 2026, reporting the sale of 4,000 shares of common stock on August 20, 2026, pursuant to a pre-established Rule 10b5-1 …
Fred Joseph Deutsch, Executive Vice President and Director of First Community Corp /SC/, filed a Form 4 on August 24, 2026, reporting the sale of common stock on August 21 and August 24, 2026, as disclosed to the U.S. Securities and Exchange Commission.
Director Paul W. Chung filed a Form 4 with the SEC on August 24, 2026, reporting a disposition of 1,000 shares of Targa Resources Corp. common stock on August 20, 2026, via a gift transaction at a price of $0.
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corporation (NASDAQ:UTHR), filed a Form 4 on August 24, 2026, disclosing the exercise of stock options and subsequent sale of common stock on August 21, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.